Literature DB >> 29331302

Bone matrix microdamage and vascular changes characterize bone marrow lesions in the subchondral bone of knee osteoarthritis.

Dzenita Muratovic1, David M Findlay2, Flavia M Cicuttini3, Anita E Wluka4, Yea-Rin Lee5, Julia S Kuliwaba6.   

Abstract

INTRODUCTION: Bone marrow lesions (BMLs) in the subchondral bone in osteoarthritis (OA) are suggested to be multifactorial, although the pathogenic mechanisms are unknown. Bone metabolism and cardiovascular risk factors associate with BML in epidemiologic studies. However, there are no studies at the tissue level investigating the relationship between these processes and BML. The aim of this study was to investigate the relationship between BMLs in the tibial plateau (TP) of knee OA and bone matrix microdamage, osteocyte density and vascular changes.
METHODS: TP were obtained from 73 patients at total knee replacement surgery and BMLs were identified ex vivo in TP tissue using MRI. Comparator 'No BML' tissue was from matched anatomical sites to the BMLs. Quantitative assessment was made of subchondral bone microdamage, bone resorption indices, osteocyte cellularity, and vascular features.
RESULTS: Several key parameters were different between BML and No BML tissue. These included increased microcrack burden (p = .01, p = .0001), which associated positively with bone resorption and negatively with cartilage volume, and greater osteocyte numerical density (p = .02, p = .01), in the subchondral bone plate and subchondral trabeculae, respectively. The marrow tissue within BML zones contained increased arteriolar density (p = .04, p = .0006), and altered vascular characteristics, in particular increased wall thickness (p = .007) and wall:lumen ratio (wall thickness over internal lumen area) (p = .001), compared with No BML bone.
CONCLUSIONS: Increased bone matrix microdamage and altered vasculature in the subchondral bone of BMLs is consistent with overloading and vascular contributions to the formation of these lesions. Given the important role of BMLs in knee OA, these contributing factors offer potential targets for the treatment and prevention of knee OA. Crown
Copyright © 2018. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone marrow lesions; knee osteoarthritis; microdamage; osteocytes; subchondral bone; vascular

Mesh:

Year:  2018        PMID: 29331302     DOI: 10.1016/j.bone.2018.01.012

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  12 in total

1.  A novel approach for rapid cell assessment to estimate DNA recovery from human bone tissue.

Authors:  Thien Ngoc Le; Oliva Handt; Julianne Henry; Adrian Linacre
Journal:  Forensic Sci Med Pathol       Date:  2021-10-11       Impact factor: 2.456

Review 2.  Osteoarthritis Pathophysiology: Therapeutic Target Discovery may Require a Multifaceted Approach.

Authors:  Tonia L Vincent; Tamara Alliston; Mohit Kapoor; Richard F Loeser; Linda Troeberg; Christopher B Little
Journal:  Clin Geriatr Med       Date:  2022-05       Impact factor: 3.529

Review 3.  Pathogenesis and clinical management of obesity-related knee osteoarthritis: Impact of mechanical loading.

Authors:  Lianzhi Chen; Jessica Jun Yi Zheng; Guangyi Li; Jun Yuan; Jay R Ebert; Hengyuan Li; John Papadimitriou; Qingwen Wang; David Wood; Christopher W Jones; Minghao Zheng
Journal:  J Orthop Translat       Date:  2020-05-15       Impact factor: 5.191

Review 4.  Hypertension meets osteoarthritis - revisiting the vascular aetiology hypothesis.

Authors:  Karen Ching; Xavier Houard; Francis Berenbaum; Chunyi Wen
Journal:  Nat Rev Rheumatol       Date:  2021-07-27       Impact factor: 20.543

5.  The simultaneous analysis of mesenchymal stem cells and early osteocytes accumulation in osteoarthritic femoral head sclerotic bone.

Authors:  Dragos C Ilas; Sarah M Churchman; Thomas Baboolal; Peter V Giannoudis; Joseph Aderinto; Dennis McGonagle; Elena Jones
Journal:  Rheumatology (Oxford)       Date:  2019-10-01       Impact factor: 7.580

Review 6.  Diversity of Vascular Niches in Bones and Joints During Homeostasis, Ageing, and Diseases.

Authors:  Naveen Kumar; Pepijn Saraber; Zhangfan Ding; Anjali P Kusumbe
Journal:  Front Immunol       Date:  2021-12-17       Impact factor: 7.561

7.  Metformin attenuates osteoclast-mediated abnormal subchondral bone remodeling and alleviates osteoarthritis via AMPK/NF-κB/ERK signaling pathway.

Authors:  Haohui Guo; Dong Ding; Limei Wang; Jiangbo Yan; Long Ma; Qunhua Jin
Journal:  PLoS One       Date:  2021-12-16       Impact factor: 3.240

Review 8.  Animal Models of Bone Marrow Lesions in Osteoarthritis.

Authors:  Andrew Bowen; David Shamritsky; Josue Santana; Ian Porter; Erica Feldman; Sarah L Pownder; Matthew F Koff; Kei Hayashi; Christopher J Hernandez
Journal:  JBMR Plus       Date:  2022-02-15

9.  Novel Ex Vivo Human Osteochondral Explant Model of Knee and Spine Osteoarthritis Enables Assessment of Inflammatory and Drug Treatment Responses.

Authors:  Jeroen Geurts; Doria Jurić; Miriam Müller; Stefan Schären; Cordula Netzer
Journal:  Int J Mol Sci       Date:  2018-04-28       Impact factor: 5.923

10.  Raman microspectroscopy demonstrates reduced mineralization of subchondral bone marrow lesions in knee osteoarthritis patients.

Authors:  Yea-Rin Lee; David M Findlay; Dzenita Muratovic; Tiffany K Gill; Julia S Kuliwaba
Journal:  Bone Rep       Date:  2020-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.